Impact of lipoprotein (a) on coronary atherosclerosis and plaque progression in patients with type 2 diabetes mellitus
European Radiology · 2025
DOI: 10.1007/s00330-024-11313-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2025. Verfasst von Ziting Lan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Coronary Artery Disease, Plaque, Atherosclerotic, Lipoprotein(a). Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenkang 3-year project of clinical innovation, Shanghai Committee of Science and Technology.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVES: To explore the association between baseline Lp (a) levels and high-risk plaques, plaque volume, and plaque progression in patients with diabetes mellitus. METHODS: Patients with diabetes mellitus and intermediate pretest probability of coronary artery disease (CAD) were prospectively enrolled. All patients underwent baseline coronary computed tomography angiography (CCTA), and patients with recurrent symptoms underwent mid-term follow-up CCTA. Plaque quantification and qualification were performed to compare coronary atherosclerosis features and plaque progression between the elevated and normal Lp (a) groups. RESULTS: In this study, 1694 subjects (mean age: 62.0 ± 7.0 years; 1031 males) were enrolled for baseline analysis, and 246 subjects with repeat CCTA (mean interval of 2.3 ± 0.74 years) were included for follow-up analysis. The total plaque volume, noncalcified plaque volume, low attenuation plaque (LAP) volume, fibro-fatty plaque volume, and fibrotic plaque volume were higher in the elevated Lp (a) group than in the normal Lp (a) group at baseline (all p < 0.001). At follow-up, the elevated Lp (a) group showed a higher mean annual increase in LAP volume than the normal Lp (a) group (3.03 ± 22.26 mm3 vs -3.09 ± 12.22 mm3; p = 0.011). In multivariate linear regression analysis, elevated Lp (a) levels were associated with accelerated LAP volume progression after adjusting for confounders (Beta = 4.50, 95% confidence interval: 0.06-8.93; p = 0.045). CONCLUSION: Elevated Lp (a) level in patients with diabetes mellitus was associated with high coronary artery plaque burden at baseline and LAP volume progression at follow-up. KEY POINTS: Question The relationship between Lp (a) levels and coronary artery plaque volume and progression in patients with diabetes mellitus remains unclear. Findings Elevated Lp (a) level was associated with high total coronary plaque volume at baseline and low-attenuation plaque (LAP) volume progression at follow-up. Clinical relevance Elevated Lp (a) level in patients with diabetes mellitus was associated with high coronary artery plaque burden at baseline and LAP volume progression at follow-up, which supports the modulation of LAP level to improve prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. yyffwang@sina.com.
- Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. andrewssmu@msn.com.
- Faculty of Medical Imaging Technology, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. andrewssmu@msn.com.
Förderung
- National Natural Science Foundation of China
- Shenkang 3-year project of clinical innovation
- Shanghai Committee of Science and Technology
- Shanghai Health Commission Discipline Leader Project
Zitieren
APA
Lan, Z., Ding, X., Yang, W., Yuan, J., Yu, Y., Yu, L., Dai, X., Wang, Y., & Zhang, J. (2025). Impact of lipoprotein (a) on coronary atherosclerosis and plaque progression in patients with type 2 diabetes mellitus. European Radiology. https://doi.org/10.1007/s00330-024-11313-2
Vancouver
Lan Z, Ding X, Yang W, Yuan J, Yu Y, Yu L, et al. Impact of lipoprotein (a) on coronary atherosclerosis and plaque progression in patients with type 2 diabetes mellitus. European Radiology. 2025. doi:10.1007/s00330-024-11313-2
BibTeX
@article{Lan2025,
author = {Lan, Ziting and Ding, Xiaoying and Yang, Wenli and Yuan, Jiajun and Yu, Yarong and Yu, Lihua and Dai, Xu and Wang, Yufan and Zhang, Jiayin},
title = {Impact of lipoprotein (a) on coronary atherosclerosis and plaque progression in patients with type 2 diabetes mellitus},
journal = {European Radiology},
year = {2025},
doi = {10.1007/s00330-024-11313-2}
}
EUVIMED